NBIX icon

Neurocrine Biosciences

417 hedge funds and large institutions have $11.1B invested in Neurocrine Biosciences in 2020 Q2 according to their latest regulatory filings, with 89 funds opening new positions, 168 increasing their positions, 112 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

9% more call options, than puts

Call options by funds: $71.2M | Put options by funds: $65.4M

0.79% less ownership

Funds ownership: 98.94%98.16% (-0.79%)

11% less funds holding in top 10

Funds holding in top 10: 98 (-1)

Holders
417
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
8
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$71.2M
Puts
$65.4M
Net Calls
Net Calls Change

Top Buyers

1 +$132M
2 +$117M
3 +$93.4M
4
Macquarie Group
Macquarie Group
Australia
+$82.6M
5
BlackRock
BlackRock
New York
+$67.3M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$1.03B
2
$1.02B
3
$916M
4
$815M
5
$792M
6
$744M
7
$392M
8
$279M
9
$261M
10
$238M
11
$189M
12
$181M
13
$167M
14
$159M
15
$145M
16
$135M
17
$119M
18
$115M
19
$111M
20
$111M
21
$110M
22
$108M
23
$106M
24
$105M
25
$91.8M